Two-Year Efficacy And Safety Of Velaglucerase Alfa In Patients With Type 1 Gaucher Disease Switching From Imiglucerase: Phase III Trial HGT-GCB-039 And Extension


Conference Paper

Full Text

Duke Authors

Cited Authors

  • Crombez, E; Kishnani, P; Turkia, HB; Gonzalez, D; Zimran, A; Kabra, M; Lukina, E; Giraldo, P; Kisinovsky, I; Bavdekar, A; Dridi, M-FB; Gupta, N

Published Date

  • February 2012

Published In

Volume / Issue

  • 105 / 2

Start / End Page

  • S25 - S26

Published By

International Standard Serial Number (ISSN)

  • 1096-7192

Digital Object Identifier (DOI)

  • 10.1016/j.ymgme.2011.11.044